Submission Details
| 510(k) Number | K251916 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 23, 2025 |
| Decision Date | March 13, 2026 |
| Days to Decision | 263 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K251916 is an FDA 510(k) clearance for the GenBody COVID-19 Ag Home Test, a Over-the-counter Covid-19 Antigen Test (Class II — Special Controls, product code QYT), submitted by Genbody.Inc. (Cheonan-Si, KR). The FDA issued a Cleared decision on March 13, 2026, 263 days after receiving the submission on June 23, 2025. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3984.
| 510(k) Number | K251916 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 23, 2025 |
| Decision Date | March 13, 2026 |
| Days to Decision | 263 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | QYT — Over-the-counter Covid-19 Antigen Test |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3984 |
| Definition | For The Rapid, Qualitative Detection Of Sars-cov-2 Virus Nucleocapsid Protein Antigen In Individuals 2 Years And Older. |